BOT-501

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameBOT-501
Drug Alias NameBOT-501
ClassificationOther
Mechanisms of ActionPlatelet-derived growth factor receptor beta modulators
TargetsPlatelet-derived growth factor receptor beta
Therapy Area/IndicationsRenal fibrosisLiver Cirrhosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiorion Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiorion Technologies
Active IndicationsN/A
Inactive IndicationsRenal fibrosisLiver Cirrhosis

Other Information

ATC CodeN/A
Related LinksN/A